Equities Analysts Set Expectations for CNTA Q3 Earnings
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Free Report) – Analysts at Leerink Partnrs issued their Q3 2025 EPS estimates for shares of Centessa Pharmaceuticals in a research note issued to investors on Monday, March 24th. Leerink Partnrs analyst D. Risinger anticipates that the company will earn ($0.40) per share for the quarter. The consensus estimate for […]
